Evidence map›Paper›PMID 32301288›Full record

ReviewWiley interdisciplinary reviews. RNA2020

Naturally occurring modified ribonucleosides.

Phillip J McCown, Agnieszka Ruszkowska, Charlotte N Kunkler, Kurtis Breger, Jacob P Hulewicz, Matthew C Wang, Noah A Springer, Jessica A Brown

Open access · bronzeAbstract readReview
In one paragraph

Review in Wiley interdisciplinary reviews. RNA, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 123 papers.

0numbers the graph read from it
0cells of the map it votes in
123citing papers in PubMed
9.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

123 citing papers in PubMed, 203 citations in OpenAlex.

  1. Article
  2. Article
  3. Catalytic and regulatory basis of tRNA tNature communications · 2026
    Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Chalcogen-modified Nucleic Acid Analogues.Current medicinal chemistry · 2026
    Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Synthesis of Nucleoside Derivatives by Biomimetic Ester Migration.Chembiochem : a European journal of chemical biology · 2025
    Article

63 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Phillip J McCownDepartment of Chemistry and Biochemistry, University of Notre Dame, Notre Dame, Indiana, USA.ORCID 0000-0002-8012-1931
Agnieszka RuszkowskaDepartment of Chemistry and Biochemistry, University of Notre Dame, Notre Dame, Indiana, USA.ORCID 0000-0002-9862-4406
Charlotte N KunklerDepartment of Chemistry and Biochemistry, University of Notre Dame, Notre Dame, Indiana, USA.ORCID 0000-0001-9319-6652
Kurtis BregerDepartment of Chemistry and Biochemistry, University of Notre Dame, Notre Dame, Indiana, USA.ORCID 0000-0003-0066-4483
Jacob P HulewiczDepartment of Chemistry and Biochemistry, University of Notre Dame, Notre Dame, Indiana, USA.ORCID 0000-0003-1726-5294
Matthew C WangDepartment of Chemistry and Biochemistry, University of Notre Dame, Notre Dame, Indiana, USA.ORCID 0000-0001-7683-2530
Noah A SpringerDepartment of Chemistry and Biochemistry, University of Notre Dame, Notre Dame, Indiana, USA.ORCID 0000-0001-8868-0415
Jessica A BrownDepartment of Chemistry and Biochemistry, University of Notre Dame, Notre Dame, Indiana, USA.ORCID 0000-0001-9055-5939
University of Notre Dame · US

Funding

Chemistry-Biochemistry-Biology Training Program at Notre DameT32GM075762 · NIGMS · UNIVERSITY OF NOTRE DAME · PI CHANG, MAYLAND F, MOBASHERY, SHAHRIAR · 2007 to 2021
$3.7M
Characterization of a Model System to Advance Triple-Stranded RNA BiologyR35GM133696 · NIGMS · UNIVERSITY OF NOTRE DAME · PI BROWN, JESSICA ANN · 2019 to 2023
$1.9M
Elucidating the Inhibitory Mechanisms of RNA Triple Helices in Nuclear DecayR00GM111430 · NIGMS · UNIVERSITY OF NOTRE DAME · PI BROWN, JESSICA ANN · 2016 to 2018
$743k
NIGMS NIH HHS R00 GM111430NIGMS NIH HHS R35 GM133696NIGMS NIH HHS T32 GM075762
6 · The paper itself

Abstract

The chemical identity of RNA molecules beyond the four standard ribonucleosides has fascinated scientists since pseudouridine was characterized as the "fifth" ribonucleotide in 1951. Since then, the ever-increasing number and complexity of modified ribonucleosides have been found in viruses and throughout all three domains of life. Such modifications can be as simple as methylations, hydroxylations, or thiolations, complex as ring closures, glycosylations, acylations, or aminoacylations, or unusual as the incorporation of selenium. While initially found in transfer and ribosomal RNAs, modifications also exist in messenger RNAs and noncoding RNAs. Modifications have profound cellular outcomes at various levels, such as altering RNA structure or being essential for cell survival or organism viability. The aberrant presence or absence of RNA modifications can lead to human disease, ranging from cancer to various metabolic and developmental illnesses such as Hoyeraal-Hreidarsson syndrome, Bowen-Conradi syndrome, or Williams-Beuren syndrome. In this review article, we summarize the characterization of all 143 currently known modified ribonucleosides by describing their taxonomic distributions, the enzymes that generate the modifications, and any implications in cellular processes, RNA structure, and disease. We also highlight areas of active research, such as specific RNAs that contain a particular type of modification as well as methodologies used to identify novel RNA modifications. This article is categorized under: RNA Processing > RNA Editing and Modification.

Indexed as

RNA Processing, Post-TranscriptionalHigh-Throughput Nucleotide SequencingHumansHydrogen BondingMass SpectrometryMetabolic Networks and PathwaysNucleic Acid ConformationRibonucleosidesSequence Analysis, RNAStructure-Activity RelationshipRibonucleosidesmRNAncRNARNA modificationrRNAtRNA

Identifiers

PMID32301288
PMCPMC7694415
OpenAlexW3017297943

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.